Sunshine Biopharma SBFM
NASDAQ SBFM
$1.14 -0.01 (-0.88%)
As of: Sep 9, 2026 · 2:14 PM EDT

Sunshine Biopharma (SBFM) Interest & Investment Income (2021 - 2026)

Sunshine Biopharma's (SBFM) quarterly Interest & Investment Income came in at $48816.0 in Q2 2026, down 32.87% on a YoY basis from $72715.0 in Q2 2025, and down 32.87% quarter-over-quarter from $72715.0 in Q2 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Sunshine Biopharma (SBFM) Interest & Investment Income (2021 - 2026) Analysis & Trends

Sunshine Biopharma (SBFM) has reported Interest & Investment Income for 3 consecutive years, with $48816.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Interest & Investment Income fell 32.87% year-over-year to $48816.0; the trailing twelve-month figure through Jun 2026 stood at $121533.0 (changed N/A YoY), and the FY2020 full-year result was $2836.0, up 107.46% from the prior year.
  • Interest & Investment Income retreated to $48816.0 in Q2 2026 per SBFM's latest filing, from $72715.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $72715.0 in Q2 2025 and bottomed at $48816.0 in Q2 2026.
Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Teva Pharmaceutical Industries 42.61 Bn 38.95 Bn 2.15 Bn -
2 Viatris 19.18 Bn 18.30 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.85 Bn 9.68 Bn 396.53 Mn 31.57 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn -55.04 Mn
5 Bausch Health Companies 2.36 Bn 518.87 Mn 2.10 Bn 11.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -16.41 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -3.64 Mn
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn 2.29 Mn
9 Fennec Pharmaceuticals 405.56 Mn 364.31 Mn 17.15 Mn 287,000.00
10 Sunshine Biopharma 1.56 Mn -12.19 Mn 2.43 Mn 48,816.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48,816.00
Jun 30, 2025 72,715.00
Jun 30, 2021 2.00